The Nose as a Route for Therapy: Part 1. Pharmacotherapy

This article reviews nasal structure and function in the light of intranasal pharmacotherapy. The nose provides an accessible, fast route for local treatment of nose and sinus diseases, with lower doses than are necessary systemically and few adverse effects. It can also be used for other medications as it has sufficient surface area protected from local damage by mucociliary clearance, absence of digestive enzymes, responsive blood flow, and provides a rapid route to the central nervous system.

[1]  C. Bachert,et al.  Correction to: Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper , 2020, Clinical and Translational Allergy.

[2]  P. Kauppi,et al.  High discontinuation rates of peroral ASA treatment for CRSwNP. A real-world multi-center study of 171 N-ERD patients. , 2020, The journal of allergy and clinical immunology. In practice.

[3]  J. Mullol,et al.  Common Cold and Acute Rhinosinusitis: Up-to-Date Management in 2020 , 2020, Current Allergy and Asthma Reports.

[4]  W. Fokkens,et al.  Direct and indirect costs of adult patients with chronic rhinosinusitis with nasal polyps. , 2020, Rhinology.

[5]  M. Mantero,et al.  Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry. , 2020, Respiratory medicine.

[6]  W. Fokkens,et al.  Executive summary of EPOS 2020 including integrated care pathways. , 2020, Rhinology.

[7]  J. Bousquet,et al.  Effect of nasal irrigation on allergic rhinitis control in children; complementarity between CARAT and MASK outcomes , 2020, Clinical and Translational Allergy.

[8]  D. Wang,et al.  European Position Paper on Rhinosinusitis and Nasal Polyps 2020. , 2020, Rhinology.

[9]  S. Loukides,et al.  Severe Eosinophilic Asthma , 2019, Journal of clinical medicine.

[10]  R. de Caterina,et al.  The first 3500 years of aspirin history from its roots - A concise summary. , 2019, Vascular pharmacology.

[11]  Chien-Yu Lin,et al.  Effectiveness of Hypertonic Saline Nasal Irrigation for Alleviating Allergic Rhinitis in Children: A Systematic Review and Meta-Analysis , 2019, Journal of clinical medicine.

[12]  Andrew A. White,et al.  Diagnosis and management of NSAID‐Exacerbated Respiratory Disease (N‐ERD)—a EAACI position paper , 2018, Allergy.

[13]  O. Niemelä,et al.  Prevalence of Patients Eligible for Anti-IL-5 Treatment in a Cohort of Adult-Onset Asthma. , 2019, The journal of allergy and clinical immunology. In practice.

[14]  G. Canonica,et al.  Adherence to treatment in allergic respiratory diseases , 2018, Expert review of respiratory medicine.

[15]  J. Perkins,et al.  NSAIDs-hypersensitivity often induces a blended reaction pattern involving multiple organs , 2018, Scientific Reports.

[16]  A. Dublin,et al.  Anatomy, Head and Neck, Nose Paranasal Sinuses , 2018 .

[17]  F. Carinci,et al.  Saline nasal irrigations for chronic rhinosinusitis: From everyday practice to evidence-based medicine. An update , 2018, International journal of immunopathology and pharmacology.

[18]  Andrew A. White,et al.  Aspirin-Exacerbated Respiratory Disease. , 2018, The New England journal of medicine.

[19]  S. Feng,et al.  The effects of nasal irrigation with various solutions after endoscopic sinus surgery: systematic review and meta-analysis. , 2018, The Journal of laryngology and otology.

[20]  E. Sapmaz,et al.  A new classification for septal perforation and effects of treatment methods on quality of life , 2018, Brazilian journal of otorhinolaryngology.

[21]  R. Harvey,et al.  Characteristics of macrolide responders in persistent post-surgical rhinosinusitis. , 2018, Rhinology.

[22]  K. Snidvongs,et al.  Hypertonic Saline Versus Isotonic Saline Nasal Irrigation: Systematic Review and Meta-analysis , 2018, American journal of rhinology & allergy.

[23]  J. Palmer,et al.  Outcomes after complete endoscopic sinus surgery and aspirin desensitization in aspirin‐exacerbated respiratory disease , 2018, International forum of allergy & rhinology.

[24]  H. Kitagawa,et al.  Immunohistochemical study on the secretory host defense system with lysozyme and secretory phospholipase A2 throughout rat respiratory tract , 2017, The Journal of veterinary medical science.

[25]  G. Scadding,et al.  Saline irrigation for allergic rhinitis. , 2017, The Cochrane database of systematic reviews.

[26]  Lysine acetylsalicylate , 2018, Reactions Weekly.

[27]  R. Simon,et al.  Safety and outcomes of aspirin desensitization for aspirin‐exacerbated respiratory disease: A single‐center study , 2018, The Journal of allergy and clinical immunology.

[28]  H. Esmaeilzadeh,et al.  Clinical and Immunological Efficacy of Aspirin Desensitization in Nasal Polyp Patients with Aspirin-Exacerbated Respiratory Disease , 2017, Iranian journal of pharmaceutical research : IJPR.

[29]  A. Romano,et al.  Aspirin challenge and desensitization: how, when and why , 2017, Current opinion in allergy and clinical immunology.

[30]  S. Durham,et al.  BSACI guideline for the diagnosis and management of allergic and non‐allergic rhinitis (Revised Edition 2017; First edition 2007) , 2017, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[31]  A. Peters,et al.  Clinical Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps, Asthma, and Aspirin-Exacerbated Respiratory Disease. , 2017, The journal of allergy and clinical immunology. In practice.

[32]  L. Rudmik,et al.  Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis , 2017, The Laryngoscope.

[33]  B. Tajudeen,et al.  The role of aspirin desensitization in the management of aspirin-exacerbated respiratory disease , 2016, Current opinion in otolaryngology & head and neck surgery.

[34]  J. Qiu,et al.  Complementary and Alternative Treatment for Allergic Conditions. , 2016 .

[35]  J. Bernstein,et al.  Combination Therapy in Allergic Rhinitis: What Works and What Does Not Work , 2016, American journal of rhinology & allergy.

[36]  M. Mäkelä,et al.  Factors affecting revision rate of chronic rhinosinusitis , 2016, Laryngoscope investigative otolaryngology.

[37]  R. Schleimer,et al.  Chronic Rhinosinusitis with Nasal Polyps. , 2016, The journal of allergy and clinical immunology. In practice.

[38]  G. Scadding,et al.  Saline irrigation for chronic rhinosinusitis. , 2016, The Cochrane database of systematic reviews.

[39]  W. Fokkens,et al.  Recent pharmacological developments in the treatment of perennial and persistent allergic rhinitis , 2016, Expert opinion on pharmacotherapy.

[40]  H. Esmaeilzadeh,et al.  Aspirin desensitization for patients with aspirin-exacerbated respiratory disease: A randomized double-blind placebo-controlled trial. , 2015, Clinical immunology.

[41]  Helen K. Reddel,et al.  A summary of the new GINA strategy: a roadmap to asthma control , 2015, European Respiratory Journal.

[42]  W. Fokkens,et al.  Capsaicin for non-allergic rhinitis. , 2015, The Cochrane database of systematic reviews.

[43]  P. Donnan,et al.  NSAID‐exacerbated respiratory disease: a meta‐analysis evaluating prevalence, mean provocative dose of aspirin and increased asthma morbidity , 2015, Allergy.

[44]  David King,et al.  Saline nasal irrigation for acute upper respiratory tract infections. , 2015, The Cochrane database of systematic reviews.

[45]  Andrew A. White,et al.  Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature. , 2015, The Journal of allergy and clinical immunology.

[46]  H. Esmaeilzadeh,et al.  Clinical and Immunological Effects of Aspirin Desensitization in Patients with Aspirin Exacerbated Respiratory Diseases; A Randomized, Double Blind, Placebo Controlled Trial , 2015 .

[47]  S. Wenzel,et al.  Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care. , 2015, The Journal of allergy and clinical immunology.

[48]  E. Nizankowska-Mogilnicka,et al.  Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a double-blind study. , 2014, The Journal of allergy and clinical immunology.

[49]  G. Scadding,et al.  Audit of nasal lysine aspirin therapy in recalcitrant aspirin exacerbated respiratory disease , 2014, The World Allergy Organization journal.

[50]  P. Hellings,et al.  Capsaicin treatment reduces nasal hyperreactivity and transient receptor potential cation channel subfamily V, receptor 1 (TRPV1) overexpression in patients with idiopathic rhinitis. , 2014, The Journal of allergy and clinical immunology.

[51]  G. Scadding,et al.  Topical nasal lysine aspirin in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitis with nasal polyposis , 2014, Expert review of clinical immunology.

[52]  J. Mullol,et al.  Fluticasone Furoate Inhibits Cytokine Secretion from Nasal Epithelial Cells and Reduces Eosinophil Survival in an in vitro Model of Eosinophilic Inflammation , 2014, International Archives of Allergy and Immunology.

[53]  G. Canonica,et al.  Pharmacotherapy of allergic rhinitis: current options and future perspectives , 2014, Expert opinion on pharmacotherapy.

[54]  E. Bleecker,et al.  International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma , 2013, European Respiratory Journal.

[55]  R. Salib,et al.  A prospective randomised single‐blinded clinical trial comparing the efficacy and tolerability of the nasal douching products Sterimar™ and Sinus Rinse™ following functional endoscopic sinus surgery , 2013, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

[56]  A. Zwinderman,et al.  Severe adult-onset asthma: A distinct phenotype. , 2013, The Journal of allergy and clinical immunology.

[57]  G. Scadding,et al.  Nasal lysine aspirin challenge in the diagnosis of aspirin - exacerbated respiratory disease , 2013, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[58]  I. Schmidtmann,et al.  Low‐dose aspirin desensitization in individuals with aspirin‐exacerbated respiratory disease , 2013, Allergy.

[59]  Andrew A. White,et al.  Aspirin desensitization in aspirin-exacerbated respiratory disease. , 2013, Immunology and allergy clinics of North America.

[60]  J. Mullol,et al.  Low prostaglandin E2 and cyclooxygenase expression in nasal mucosa fibroblasts of aspirin‐intolerant asthmatics , 2013, Respirology.

[61]  L. Teran,et al.  Aspirin-Intolerant Asthma: A Comprehensive Review of Biomarkers and Pathophysiology , 2013, Clinical Reviews in Allergy & Immunology.

[62]  P. Filipe,et al.  Mechanisms of Action of Topical Corticosteroids in Psoriasis , 2012, International journal of endocrinology.

[63]  M. Hellmich,et al.  Nasal irrigation as an adjunctive treatment in allergic rhinitis: A systematic review and meta-analysis , 2012, American journal of rhinology & allergy.

[64]  S. Holgate,et al.  Aspirin Exacerbated Respiratory Disease , 2012, Journal of allergy.

[65]  S. Esposito,et al.  Hypertonic Saline is More Effective Than Normal Saline in Seasonal Allergic Rhinitis in Children , 2012, International journal of immunopathology and pharmacology.

[66]  F. Simons,et al.  Histamine and H1-antihistamines: celebrating a century of progress. , 2011, The Journal of allergy and clinical immunology.

[67]  J Bousquet,et al.  Chronic rhinosinusitis in Europe – an underestimated disease. A GA2LEN study , 2011, Allergy.

[68]  C. Bachert,et al.  Therapeutic Index (TIX) for intranasal corticosteroids in the treatment of allergic rhinitis. , 2011, Rhinology.

[69]  N. M. Kushnir The role of decongestants, cromolyn, guafenesin, saline washes, capsaicin, leukotriene antagonists, and other treatments on rhinitis. , 2011, Immunology and allergy clinics of North America.

[70]  M. Blaiss,et al.  Management of Rhinitis: Allergic and Non-Allergic , 2011, Allergy, asthma & immunology research.

[71]  L. Giacomelli,et al.  Effects of sulfurous, salty, bromic, iodic thermal water nasal irrigations in nonallergic chronic rhinosinusitis: a prospective, randomized, double-blind, clinical, and cytological study. , 2011, American journal of otolaryngology.

[72]  K. Chapman,et al.  The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights , 2011, Molecular and Cellular Endocrinology.

[73]  E. Meltzer,et al.  Overview of the treatment of allergic rhinitis and nonallergic rhinopathy. , 2011, Proceedings of the American Thoracic Society.

[74]  R. Naclerio,et al.  Anatomy and physiology of the upper airway. , 2011, Proceedings of the American Thoracic Society.

[75]  D. Stevenson,et al.  Aspirin-Exacerbated Respiratory Disease: Evaluation and Management , 2010, Allergy, asthma & immunology research.

[76]  J. Bernstein,et al.  Azelastine HCl: A Review of the Old and New Formulations , 2010 .

[77]  Michael X. Cohen,et al.  Oxytocin Enhances Amygdala-Dependent, Socially Reinforced Learning and Emotional Empathy in Humans , 2010, The Journal of Neuroscience.

[78]  M. Kaliner,et al.  Comprehensive review of olopatadine: the molecule and its clinical entities. , 2010, Allergy and asthma proceedings.

[79]  M. Okano Mechanisms and clinical implications of glucocorticosteroids in the treatment of allergic rhinitis , 2009, Clinical and experimental immunology.

[80]  L. Pignataro,et al.  Nasal Lavage in Pregnant Women with Seasonal Allergic Rhinitis: A Randomized Study , 2009, International Archives of Allergy and Immunology.

[81]  P. Keith,et al.  Are intranasal corticosteroids all equally consistent in managing ocular symptoms of seasonal allergic rhinitis? , 2009, Current medical research and opinion.

[82]  W. Berger Pharmacokinetic characteristics and safety and tolerability of a reformulated azelastine hydrochloride nasal spray in patients with chronic rhinitis , 2009 .

[83]  A. Süslü,et al.  Effects of buffered 2.3%, buffered 0.9%, and non-buffered 0.9% irrigation solutions on nasal mucosa after septoplasty , 2009, European Archives of Oto-Rhino-Laryngology.

[84]  Xing Tang,et al.  Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[85]  E. Meltzer,et al.  Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications , 2008, Allergy.

[86]  F. Horak Effectiveness of twice daily azelastine nasal spray in patients with seasonal allergic rhinitis , 2008, Therapeutics and clinical risk management.

[87]  T. Deutschle,et al.  Long‐term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300 mg aspirin daily , 2008, Allergy.

[88]  R. Nathan,et al.  Intranasal Mometasone Furoate Alleviates the Ocular Symptoms Associated with Seasonal Allergic Rhinitis: Results of a Post Hoc Analysis , 2008, International Archives of Allergy and Immunology.

[89]  G. Viegi,et al.  Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 * , 2008, Allergy.

[90]  J. Skoupá,et al.  Efficacy of isotonic nasal wash (seawater) in the treatment and prevention of rhinitis in children. , 2008, Archives of otolaryngology--head & neck surgery.

[91]  P. Roland,et al.  An assessment of the onset and duration of action of olopatadine nasal spray , 2007, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[92]  M. Ryan,et al.  The effect of saline solutions on nasal patency and mucociliary clearance in rhinosinusitis patients , 2007, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[93]  C. Janson,et al.  Allergic rhinitis and onset of bronchial hyperresponsiveness: a population-based study. , 2007, American journal of respiratory and critical care medicine.

[94]  C. Bachert,et al.  EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity , 2007, Allergy.

[95]  G. Roomans,et al.  Effects of hyperosmotic stress on cultured airway epithelial cells , 2007, Cell and Tissue Research.

[96]  R. Garadi,et al.  Onset and duration of action of nasal sprays in seasonal allergic rhinitis patients: olopatadine hydrochloride versus mometasone furoate monohydrate. , 2007, Allergy and asthma proceedings.

[97]  J. Bernstein Azelastine hydrochloride:a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability , 2007, Current medical research and opinion.

[98]  G. Scadding,et al.  Intranasal lysine-aspirin administration decreases polyp volume in patients with aspirin-intolerant asthma. , 2007, The Journal of laryngology and otology.

[99]  P. Patel,et al.  Onset of Action of Azelastine Nasal Spray Compared with Mometasone Nasal Spray and Placebo in Subjects with Seasonal Allergic Rhinitis Evaluated in an Environmental Exposure Chamber , 2007, American journal of rhinology.

[100]  R. Simon,et al.  Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease. , 2007, The Journal of allergy and clinical immunology.

[101]  P. Barnes How corticosteroids control inflammation: Quintiles Prize Lecture 2005 , 2006, British journal of pharmacology.

[102]  D. Price,et al.  ARIA update: I--Systematic review of complementary and alternative medicine for rhinitis and asthma. , 2006, The Journal of allergy and clinical immunology.

[103]  U. Munzel,et al.  Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy , 2006, Current medical research and opinion.

[104]  W. Berger,et al.  Mometasone Furoate Improves Congestion in Patients with Moderate-to-Severe Seasonal Allergic Rhinitis , 2005, The Annals of pharmacotherapy.

[105]  E. Bleecker,et al.  Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma. , 2005, The Journal of allergy and clinical immunology.

[106]  G. Scadding,et al.  Intranasal Lysine‐Aspirin in Aspirin‐Sensitive Nasal Polyposis: A Controlled Trial , 2005, The Laryngoscope.

[107]  G. Sambataro,et al.  Nasal Rinsing with Hypertonic Solution: An Adjunctive Treatment for Pediatric Seasonal Allergic Rhinoconjunctivitis , 2005, International Archives of Allergy and Immunology.

[108]  J. Bernstein,et al.  Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis. , 2005, Clinical therapeutics.

[109]  G. Scadding,et al.  Expression of the cysteinyl leukotriene receptors cysLT(1) and cysLT(2) in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitis. , 2005, The Journal of allergy and clinical immunology.

[110]  K. Tano,et al.  A Daily Nasal Spray with Saline Prevents Symptoms of Rhinitis , 2004, Acta oto-laryngologica.

[111]  M. Ryan,et al.  Effects of Buffered Saline Solution on Nasal Mucociliary Clearance and Nasal Airway Patency , 2004, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[112]  F. Merkus,et al.  Uptake of estradiol or progesterone into the CSF following intranasal and intravenous delivery in rats. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[113]  T. Craig,et al.  Inflammatory Responses in Allergic Rhinitis: Traditional Approaches and Novel Treatment Strategies , 2004, The Journal of the American Osteopathic Association.

[114]  K. Rickard,et al.  The efficacy of intranasal fluticasone propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis. , 2003, Allergy and asthma proceedings.

[115]  S. Plontke,et al.  Investigating the Nasal Cycle Using Endoscopy, Rhinoresistometry, and Acoustic Rhinometry , 2003, The Laryngoscope.

[116]  G. Rettinger,et al.  The relationship between water vapour saturation of inhaled air and nasal patency , 2003, European Respiratory Journal.

[117]  M. Andersson,et al.  Hypertonic saline increases secretory and exudative responsiveness of human nasal airway in vivo , 2003, European Respiratory Journal.

[118]  M. Mundt,et al.  Efficacy of daily hypertonic saline nasal irrigation among patients with sinusitis: a randomized controlled trial. , 2002, The Journal of family practice.

[119]  G. Scadding,et al.  Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. , 2002, The New England journal of medicine.

[120]  R. Simon,et al.  The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. , 2002, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[121]  G. Rodrigo,et al.  Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis. , 2002, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[122]  S. Garg,et al.  Permeability issues in nasal drug delivery. , 2002, Drug discovery today.

[123]  A. Nagler,et al.  Dexamethasone inhibits maturation, cytokine production and FcεRI expression of human cord blood‐derived mast cells , 2002 .

[124]  Q. Hamid,et al.  Intrasinus Administration of Topical Budesonide to Allergic Patients With Chronic Rhinosinusitis Following Surgery , 2002, The Laryngoscope.

[125]  R. Leurs,et al.  H1‐antihistamines: inverse agonism, anti‐inflammatory actions and cardiac effects , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[126]  M. Gillard,et al.  Binding characteristics of cetirizine and levocetirizine to human H(1) histamine receptors: contribution of Lys(191) and Thr(194). , 2002, Molecular pharmacology.

[127]  J. Bousquet,et al.  Allergic rhinitis and its impact on asthma. , 2001, The Journal of allergy and clinical immunology.

[128]  C. Caruso,et al.  Measurement of Inflammatory Mediators of Mast Cells and Eosinophils in Native Nasal Lavage Fluid in Nasal Polyposis , 2001, International Archives of Allergy and Immunology.

[129]  H. Hoogsteden,et al.  Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. , 2001, The Journal of allergy and clinical immunology.

[130]  A. Ishii,et al.  Effects of olopatadine hydrochloride on the release of thromboxane B2 and histamine from nasal mucosa after antigen–antibody reaction in guinea pigs , 2001 .

[131]  G. Hommel,et al.  Effect of irrigation of the nose with isotonic salt solution on adult patients with chronic paranasal sinus disease , 2000, European Archives of Oto-Rhino-Laryngology.

[132]  G. Paludetti,et al.  Effects of lysine-acetylsalicylate (LAS) treatment in nasal polyposis: two controlled long term prospective follow up studies , 2000, Thorax.

[133]  P. Barnes,et al.  New directions in allergic diseases: mechanism-based anti-inflammatory therapies. , 2000, The Journal of allergy and clinical immunology.

[134]  L. Klimek,et al.  Aktuelle Aspekte der nasalen Glukokortikosteroidtherapie , 2000, HNO.

[135]  J. Homer,et al.  The effect of hypertonicity on nasal mucociliary clearance. , 2000, Clinical otolaryngology and allied sciences.

[136]  C. Shim,et al.  Prolonged delivery of nicotine in rats via nasal administration of proliposomes. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[137]  J Bousquet,et al.  Consensus statement * on the treatment of allergic rhinitis , 2000, Allergy.

[138]  H. Hoogsteden,et al.  Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients. , 2000, American journal of respiratory and critical care medicine.

[139]  R. Leurs,et al.  Mutational Analysis of the Antagonist-binding Site of the Histamine H1 Receptor* , 1999, The Journal of Biological Chemistry.

[140]  R. Schleimer,et al.  An in vitro comparison of commonly used topical glucocorticoid preparations. , 1999, The Journal of allergy and clinical immunology.

[141]  T. Craig,et al.  Efficacy and safety of azelastine nasal spray for the treatment of allergic rhinitis , 1999, The Journal of the American Osteopathic Association.

[142]  M. Carlston A clinical trial of hypertonic saline nasal spray. , 1999, Archives of family medicine.

[143]  R. Puy,et al.  Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials , 1998, BMJ.

[144]  Nakahata,et al.  The effects of anti‐asthma drugs on mediator release from cultured human mast cells , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[145]  S. Matsuo,et al.  Influence of the anti-allergic agent, azelastine, on tumor necrosis factor-alpha (TNF-alpha) secretion from cultured mouse mast cells. , 1998, In vivo.

[146]  L. Mastalerz,et al.  Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma. , 1998, The Journal of allergy and clinical immunology.

[147]  D. Shoseyov,et al.  Treatment with hypertonic saline versus normal saline nasal wash of pediatric chronic sinusitis. , 1998, The Journal of allergy and clinical immunology.

[148]  R. Blake,et al.  A clinical trial of hypertonic saline nasal spray in subjects with the common cold or rhinosinusitis. , 1998, Archives of family medicine.

[149]  D. Tinkelman,et al.  The anticholinergic agent, ipratropium bromide, is useful in the treatment of rhinorrhea associated with perennial allergic rhinitis. , 1998, Allergy and asthma proceedings.

[150]  M. Billah,et al.  The inhibitory effects of topically active glucocorticoids on IL-4, IL-5, and interferon-gamma production by cultured primary CD4+ T cells. , 1997, The Journal of allergy and clinical immunology.

[151]  S. Yamamoto,et al.  Suppression of TNF-alpha secretion by azelastine in a rat mast (RBL-2H3) cell line: evidence for differential regulation of TNF-alpha release, transcription, and degranulation. , 1997, Journal of immunology.

[152]  David S. Parsons,et al.  Mucociliary Clearance and Buffered Hypertonic Saline Solution , 1997, The Laryngoscope.

[153]  M. Andersson,et al.  Topical azelastine has a 12‐hour duration of action as assessed by histamine challenge‐induced exudation of α2‐macroglobulin into human nasal airways , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[154]  R. Doty,et al.  Influence of Age on the ‘Nasal Cycle’ , 1997, The Laryngoscope.

[155]  R. Simon,et al.  Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes. , 1996, The Journal of allergy and clinical immunology.

[156]  B. Fisch,et al.  Intranasal nafarelin versus buserelin (short protocol) for controlled ovarian hyperstimulation before in vitro fertilization: a prospective clinical trial. , 1996, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[157]  J. M. Cousin,et al.  Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. , 1996, Journal of immunology.

[158]  S. Yamamoto,et al.  Inhibition of leukotriene synthesis by azelastine. , 1996, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[159]  S. Xu,et al.  Olopatadine (AL-4943A): ligand binding and functional studies on a novel, long acting H1-selective histamine antagonist and anti-allergic agent for use in allergic conjunctivitis. , 1996, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[160]  G. Scadding,et al.  Intranasal lysine aspirin in recurrent nasal polyposis. , 1995, Clinical otolaryngology and allied sciences.

[161]  M. Johnson,et al.  Fluticasone propionate--an update on preclinical and clinical experience. , 1995, Respiratory medicine.

[162]  G. K. Scadding Rhinitis medicamentosa , 1995, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[163]  T. Yagi,et al.  [Fluticasone propionate reduced the production of GM-CSF, IL-6 and IL-8 generated from cultured nasal epithelial cells]. , 1994, Arerugi = [Allergy].

[164]  A. Sala,et al.  Effects of loratadine on cytosolic Ca2+ levels and leukotriene release: novel mechanisms of action independent of the anti-histamine activity. , 1994, European journal of pharmacology.

[165]  S. Gizurarson The relevance of nasal physiology to the design of drug absorption studies , 1993 .

[166]  E. Meltzer,et al.  Ipratropium bromide aqueous nasal spray for patients with perennial allergic rhinitis: a study of its effect on their symptoms, quality of life, and nasal cytology. , 1992, The Journal of allergy and clinical immunology.

[167]  Y. Sugimoto,et al.  The effects of the serotonin1A receptor agonist buspirone on the blood glucose and pancreatic hormones in rats. , 1992, Japanese journal of pharmacology.

[168]  G. Papa,et al.  Intranasal treatment with lysine acetylsalicylate in patients with nasal polyposis. , 1991, Annals of allergy.

[169]  J. Kemp,et al.  Comparison of intranasal cromolyn sodium, 4%, and oral terfenadine for allergic rhinitis: symptoms, nasal cytology, nasal ciliary clearance, and rhinomanometry. , 1991, Annals of allergy.

[170]  R. Sofia,et al.  Inhibition of allergic and nonallergic leukotriene C4 formation and histamine secretion by azelastine: implication for its mechanism of action. , 1989, International archives of allergy and applied immunology.

[171]  N. Johnson,et al.  Effects of sodium cromoglycate and nedocromil sodium on histamine secretion from human lung mast cells. , 1988, Thorax.

[172]  W. Wingert,et al.  Medicated versus saline nose drops in the management of upper respiratory infection. , 1984, Helvetica paediatrica acta.

[173]  P. Borum,et al.  Intranasal ipratropium: a new treatment for perennial rhinitis. , 1979, Clinical otolaryngology and allied sciences.

[174]  Alasdair Breckenridge,et al.  Meyler's Side Effects of Drugs , 1976 .

[175]  G. Storey,et al.  Beclomethasone Dipropionate: A New Steroid Aerosol for the Treatment of Allergic Asthma , 1972, British medical journal.

[176]  P. Norman American academy of allergy 25th anniversary series: A rational approach to desensitization , 1969 .

[177]  L. Gray Deviated nasal septum. 3. Its influence on the physiology and disease of the nose and ear. I. , 1967, The Journal of laryngology and otology.

[178]  R. Settipane,et al.  Allergic rhinitis , 2005, Rhinology and Anterior Skull Base Surgery.

[179]  H. Haas [Histamine and antihistamines]. , 1951, Arzneimittel-Forschung.